Not Making Headlines...
Japan’s Kowa Company Finds Ivermectin is Effective Against Omicron and Other COVID-19 Variants
Kowa Company Ltd, a Japanese company specializing in trading and sales of medicines and medical equipment, announced on Monday that Ivermectin has an “antiviral effect” against Omicron and other COVID-19 variants as Phase III clinical trials continue
Gateway Pundit
